Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in ...

Anti-drug antibody positivity often paralleled B-cell reconstitution and did not uniformly predict rituximab failure.

HOUSTON, JULY 7, 2026 ― Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in ...

Company AnnouncementTopline results from Phase 3 EPCORE® DLBCL-4 evaluating epcoritamab in combination with lenalidomide demonstrated ...

Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative ...

Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, b-thalassemia, ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). The company’s tetraspecific antibody controlled tumors and improved survival in mice and ...

For the immune system to effectively combat pathogens, antibody responses must be precisely controlled. So-called follicular ...